Saturday 17 October 2026
Export ROIV’s income statement to Excel — free account
Roivant Sciences Ltd.
ROIV Healthcare Biotechnology
In the quarter to June 2026, revenue fell 33.6%, EPS grew 21.2% and free cash flow fell 30.0%, each against the same quarter a year earlier.
33.53
0.51
−1.50%
Follow ROIV
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Dec '20 | |
|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
4,291.83 | 4,886.89 | 6,494.95 | 1,676.81 | 2,060.40 | 2,132.75 | 1.70 |
Receivables |
770.24 | — | — | — | — | — | 0.00 |
Other current assets |
105.32 | 113.17 | 80.61 | 121.77 | 86.12 | 54.25 | 0.28 |
Total current assets |
5,167.38 | 5,000.06 | 6,731.83 | 1,798.59 | 2,146.52 | 2,187.00 | 1.98 |
Property, Plant, Equpment (Net) |
11.99 | 12.06 | 15.32 | 39.09 | 25.91 | 14.75 | — |
Long-Term Investments |
407.99 | 302.94 | 247.75 | 304.32 | 325.83 | 289.54 | 410.80 |
Goodwill and Intangible Assets (Total) |
— | — | 137.84 | 144.88 | — | — | — |
Long-term assets (Other) |
40.92 | 32.86 | 37.70 | 49.48 | 25.82 | 36.13 | — |
Total non-current assets |
541.30 | 436.88 | 490.65 | 591.02 | 438.61 | 402.70 | — |
Total Assets |
5,708.69 | 5,436.94 | 7,222.48 | 2,389.60 | 2,585.13 | 2,589.69 | 412.78 |
Accounts Payable |
18.00 | 23.69 | 14.03 | 37.83 | 34.58 | 20.55 | — |
Accrued Expenses |
205.82 | 114.29 | 119.42 | 167.13 | 127.53 | 76.94 | — |
Current Part of Debt |
— | — | 12.00 | 40.72 | — | — | — |
Current Part of Taxes to Pay |
45.69 | 0.42 | — | — | — | — | — |
Current Revenue (Deferred) |
— | — | — | — | 10.15 | 5.92 | — |
Other current liabilities |
0.58 | 1.17 | 13.94 | 15.08 | 10.86 | 103.24 | 0.54 |
Total current liabilities |
281.24 | 149.41 | 266.76 | 272.45 | 184.37 | 218.96 | 0.55 |
Long Term Debt (Total) |
— | — | 430.59 | 375.52 | 210.03 | 170.28 | — |
Minority Interests |
— | — | — | — | 22.49 | 22.49 | — |
Non-current Liabilities (Other) |
38.74 | 10.00 | 28.23 | 80.58 | 66.84 | 76.06 | 14.38 |
Total non-current liabilities |
135.03 | 100.33 | 507.20 | 509.57 | 361.82 | 331.22 | — |
Total liabilities |
416.28 | 249.74 | 773.95 | 782.02 | 546.19 | 550.18 | 14.93 |
Additional Paid In Capital |
5,024.83 | 4,562.11 | 5,396.49 | 4,933.14 | 4,421.61 | 3,814.81 | — |
Common Stock (Net) |
— | — | — | — | — | — | 392.85 |
Retained Earnings |
(501.81) | 116.06 | 576.17 | (3,772.75) | (2,763.72) | (1,918.46) | (0.39) |
Shareholders Equity (Other) |
— | — | — | — | — | (100.00) | — |
Common Equity (Total) |
5,292.41 | 5,187.20 | 6,448.53 | 1,607.59 | 2,038.94 | 2,039.51 | 397.85 |
Shareholders Equity (Total) |
5,292.41 | 5,187.20 | 6,448.53 | 1,607.59 | 2,038.94 | 2,039.51 | 397.85 |
Shareholders Equity and Liabilities (Total) |
5,708.69 | 5,436.94 | 7,222.48 | 2,389.60 | 2,585.13 | 2,589.69 | — |
Shares (Common) |
720.35 | 695.94 | 806.68 | 760.14 | 694.98 | 651.58 | — |
Shareholders Equity (Tangible) |
5,292.41 | 5,187.20 | 6,448.53 | 1,462.71 | 2,038.94 | 2,039.51 | — |
Net Debt |
(4,291.83) | (4,886.89) | (6,052.36) | (1,260.58) | (1,850.37) | (1,962.46) | (1.70) |
Total Debt |
— | — | 442.59 | 416.24 | 210.03 | 170.28 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 1 Oct 2026